These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34192317)

  • 1. Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice.
    Shin B; Hrdlicka HC; Delany AM; Lee SK
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34192317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The miR-29-3p family suppresses inflammatory osteolysis.
    Shin B; Hrdlicka HC; Karki S; Fraser B; Lee SK; Delany AM
    J Cell Physiol; 2024 Aug; 239(8):e31299. PubMed ID: 38764231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis.
    Lu D; Li J; Liu H; Foxa GE; Weaver K; Li J; Williams BO; Yang T
    J Bone Miner Res; 2018 Oct; 33(10):1773-1784. PubMed ID: 29750835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Lineage Ablation of
    Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
    Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
    Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
    J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone anabolism.
    Hrdlicka HC; Pereira RC; Shin B; Yee SP; Deymier AC; Lee SK; Delany AM
    Bone; 2021 Feb; 143():115779. PubMed ID: 33253931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration.
    Franceschetti T; Kessler CB; Lee SK; Delany AM
    J Biol Chem; 2013 Nov; 288(46):33347-60. PubMed ID: 24085298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
    Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
    Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-
    Ahn SH; Chen Z; Lee J; Lee SW; Min SH; Kim ND; Lee TH
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30501117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
    Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
    Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
    Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
    Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
    PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
    Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal bone architecture in mice expressing MyD88 in cells of the osteoclast lineage.
    Suren C; Lukashova L; Wischmann J; Wulsten D; Wildemann B; Von Eisenhart-Rothe R; Holzmann B; Mayer-Kuckuk P
    J Biol Regul Homeost Agents; 2019; 33(4):1105-1111. PubMed ID: 31332987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.